IBDEI2FW ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41379,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,41380,0)
 ;;=D75.1^^159^2004^180
 ;;^UTILITY(U,$J,358.3,41380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41380,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,41380,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,41380,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,41381,0)
 ;;=C90.30^^159^2004^183
 ;;^UTILITY(U,$J,358.3,41381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41381,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,41381,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,41381,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,41382,0)
 ;;=D56.3^^159^2004^184
 ;;^UTILITY(U,$J,358.3,41382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41382,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,41382,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,41382,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,41383,0)
 ;;=D56.9^^159^2004^185
 ;;^UTILITY(U,$J,358.3,41383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41383,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,41383,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,41383,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,41384,0)
 ;;=M31.1^^159^2004^187
 ;;^UTILITY(U,$J,358.3,41384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41384,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,41384,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,41384,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,41385,0)
 ;;=D51.2^^159^2004^188
 ;;^UTILITY(U,$J,358.3,41385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41385,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,41385,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,41385,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,41386,0)
 ;;=D05.92^^159^2004^35
 ;;^UTILITY(U,$J,358.3,41386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41386,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,41386,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,41386,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,41387,0)
 ;;=D05.91^^159^2004^37
 ;;^UTILITY(U,$J,358.3,41387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41387,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,41387,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,41387,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,41388,0)
 ;;=D05.90^^159^2004^33
 ;;^UTILITY(U,$J,358.3,41388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41388,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,41388,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,41388,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,41389,0)
 ;;=D51.0^^159^2004^189
 ;;^UTILITY(U,$J,358.3,41389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41389,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,41389,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,41389,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,41390,0)
 ;;=D51.1^^159^2004^190
 ;;^UTILITY(U,$J,358.3,41390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41390,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,41390,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,41390,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,41391,0)
 ;;=D51.9^^159^2004^192
 ;;^UTILITY(U,$J,358.3,41391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41391,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,41391,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,41391,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,41392,0)
 ;;=D68.0^^159^2004^194
 ;;^UTILITY(U,$J,358.3,41392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41392,1,3,0)
 ;;=3^Von Willebrand's Disease
